首页> 外文会议>Colloidal nanoparticles for biomedical applications X >SERS active colloidal nanoparticles for the detection of small blood biomarkers using aptamers
【24h】

SERS active colloidal nanoparticles for the detection of small blood biomarkers using aptamers

机译:SERS活性胶体纳米颗粒,用于使用适体检测小血液生物标志物

获取原文
获取原文并翻译 | 示例

摘要

Functionalized colloidal nanoparticles for SERS serve as a promising multifunctional assay component for blood biomarker detection. Proper design of these nanoprobes through conjugation to spectral tags, protective polymers, and sensing ligands can provide experimental control over the sensitivity, range, reproducibility, particle stability, and integration with biorecognition assays. Additionally, the optical properties and degree of electromagnetic SERS signal enhancement can be altered and monitored through tuning the nanoparticle shape, size, material and the colloid's local surface plasmon resonance (LSPR). Aptamers, synthetic affinity ligands derived from nucleic acids, provide a number of advantages for biorecognition of small molecules and toxins with low immunogenicity. DNA aptamers are simpler and more economical to produce at large scale, are capable of greater specificity and affinity than antibodies, are easily tailored to specific functional groups, can be used to tune inter-particle distance and shift the LSPR, and their intrinsic negative charge can be utilized for additional particle stability. Herein, a "turn-off' competitive binding assay platform involving two different plasmonic nanoparticles for the detection of the toxin bisphenol A (BPA) using SERS is presented. A derivative of the toxin is immobilized onto a silver coated magnetic nanoparticle (Ag@MNP), and a second solid silver nanoparticle (AgNP) is functionalized with the BPA aptamer and a Raman reporter molecule (RRM). The capture (Ag@MNP) and probe (AgNP) particles are mixed and the aptamer binding interaction draws the nanoparticles closer together, forming an assembly that results in an increased SERS signal intensity. This aptamer mediated assembly of the two nanoparticles results in a 100x enhancement of the SERS signal intensity from the RRM. These pre-bound aptameranoparticle conjugates were then exposed to BPA in free solution and the competitive binding event was monitored by the decrease in SERS intensity.
机译:用于SERS的功能化胶体纳米颗粒可作为有前途的多功能检测组件用于血液生物标志物检测。通过与光谱标签,保护性聚合物和传感配体的缀合,对这些纳米探针进行适当的设计,可以提供对灵敏度,范围,可再现性,颗粒稳定性以及与生物识别测定法整合的实验控制。另外,可以通过调整纳米粒子的形状,大小,材料和胶体的局部表面等离子体共振(LSPR)来更改和监视电磁SERS信号增强的光学特性和程度。适体,衍生自核酸的合成亲和配体,为生物识别具有低免疫原性的小分子和毒素提供了许多优势。 DNA适体比大规模生产更简单,更经济,比抗体具有更高的特异性和亲和力,易于定制以适应特定的功能基团,可用于调节粒子间距离并移动LSPR及其固有的负电荷可用于额外的颗粒稳定性。本文介绍了一种“关掉”竞争结合测定平台,该平台涉及两个不同的等离激元纳米颗粒,用于使用SERS检测毒素双酚A(BPA)。毒素的衍生物固定在涂银的磁性纳米颗粒上(Ag @ MNP ),然后用BPA适体和拉曼报告分子(RRM)对第二个固体银纳米粒子(AgNP)进行功能化,将捕获粒子(Ag @ MNP)和探针(AgNP)混合在一起,并且适体结合相互作用将纳米粒子拉近在一起,形成一个增加SERS信号强度的组装体,这两个适体介导的组装使RRM的SERS信号强度增强100倍,然后将这些预结合的适体/纳米颗粒共轭物暴露于BPA中。游离溶液和竞争性结合事件通过SERS强度的降低来监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号